TY - JOUR
T1 - Implications of surgical intervention in the treatment of neuroblastomas
T2 - 20-year experience of a single institution
AU - Tajiri, Tatsuro
AU - Sozaki, Ryota
AU - Kinoshita, Yoshiaki
AU - Koga, Yuhki
AU - Suminoe, Aiko
AU - Hara, Toshiro
AU - Taguchi, Tomoaki
N1 - Funding Information:
This work was supported in part by a grant-in-aid for scientific research from the Japanese Society for the Promotion of Science.
PY - 2012/2
Y1 - 2012/2
N2 - Purpose: The implications of surgical intervention for neuroblastomas were assessed in one institution. Methods: We analyzed the clinical characteristics and extension of resection in 123 pediatric patients with neuroblastoma diagnosed between 1985 and 2004. Results: The 5-year survival rate of the 82 patients under 12 months of age, 59 of whom were treated with complete resection of the primary tumor, was 97%. The 5-year survival rate of the 41 patients over 12 months of age did not differ significantly according to whether complete (n = 19) or incomplete resection (n = 22) was performed (46 vs. 38%, respectively). No local recurrence was observed in ten patients over 12 months of age with stage 4 disease who underwent complete resection of the primary tumor; however, four of these ten patients died of metastatic recurrence. Conclusion: Considering that the majority of infantile neuroblastomas in this study had favorable biology, complete resection might be unnecessary for patients under 12 years of age. For advanced neuroblastomas in patients over 12 months of age, the main treatment for metastasis is systemic chemotherapy, although extirpation of the primary tumor without extensive surgery might prevent local recurrence when combined with radiation therapy.
AB - Purpose: The implications of surgical intervention for neuroblastomas were assessed in one institution. Methods: We analyzed the clinical characteristics and extension of resection in 123 pediatric patients with neuroblastoma diagnosed between 1985 and 2004. Results: The 5-year survival rate of the 82 patients under 12 months of age, 59 of whom were treated with complete resection of the primary tumor, was 97%. The 5-year survival rate of the 41 patients over 12 months of age did not differ significantly according to whether complete (n = 19) or incomplete resection (n = 22) was performed (46 vs. 38%, respectively). No local recurrence was observed in ten patients over 12 months of age with stage 4 disease who underwent complete resection of the primary tumor; however, four of these ten patients died of metastatic recurrence. Conclusion: Considering that the majority of infantile neuroblastomas in this study had favorable biology, complete resection might be unnecessary for patients under 12 years of age. For advanced neuroblastomas in patients over 12 months of age, the main treatment for metastasis is systemic chemotherapy, although extirpation of the primary tumor without extensive surgery might prevent local recurrence when combined with radiation therapy.
UR - http://www.scopus.com/inward/record.url?scp=84857652671&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857652671&partnerID=8YFLogxK
U2 - 10.1007/s00595-011-0053-0
DO - 10.1007/s00595-011-0053-0
M3 - Article
C2 - 22258728
AN - SCOPUS:84857652671
SN - 0941-1291
VL - 42
SP - 220
EP - 224
JO - Surgery today
JF - Surgery today
IS - 3
ER -